We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Promises to Defend Copaxone Patents After Firms File ANDA
Teva Promises to Defend Copaxone Patents After Firms File ANDA
July 22, 2008
Teva has vowed to protect patents covering its blockbuster multiple sclerosis (MS) treatment Copaxone after the FDA accepted Momenta and Sandoz’s ANDA for a generic version of the drug for review.